Fixed-Dose Combinations for HIV/AIDS, Tuberculosis, and Malaria - Report of a Meeting Held 16-18 December 2003 Geneva
(2003; 199 pages) Ver el documento en el formato PDF
Índice de contenido
Abrir esta carpeta y ver su contenidoSummary: Observations and some ways forward
Abrir esta carpeta y ver su contenidoWelcome
Abrir esta carpeta y ver su contenidoFixed-dose combinations for tuberculosis: lessons learned from a clinical, formulation and regulatory perspective
Abrir esta carpeta y ver su contenidoProduct costs of fixed-dose combination tablets in comparison with separate dispensing and or co-blistering of antituberculosis drugs
Abrir esta carpeta y ver su contenidoFixed-dose combinations: artemisinin-based combination therapies for malaria treatment
Abrir esta carpeta y ver su contenidoDeveloping combinations of drugs for malaria examination of critical issues and lessons learnt
Abrir esta carpeta y ver su contenidoSafety and long-term effectiveness of generic fixed-dose formulations of nevirapine-based HAART amongst antiretroviral-naïve HIV-infected patients in India
Abrir esta carpeta y ver su contenidoEffect of introduction of fixed-dose combinations on the drug supply chain: experiences from the field
Abrir esta carpeta y ver su contenidoEffect of fixed-dose combination (FDC) medications on adherence and treatment outcomes
Abrir esta carpeta y ver su contenidoEffect of fixed-dose combination (FDC) drugs on development of clinical antimicrobial resistance: a review paper
Abrir esta carpeta y ver su contenidoFixed-dose combination (FDC) drugs availability and use as a global public health necessity: intellectual property and other legal issues
Abrir esta carpeta y ver su contenidoPharmaceutical development and quality assurance of FDCs
Ver el documentoAnnotated agenda
Ver el documentoList of participants
 

List of participants

Mr. Vinod Arora
Ranbaxy Pharmaceuticals Inc.
19, Nehru Place
New Delhi
India
+91 11 26452666-72
+91 11 26002076
vinod.arora@ranbaxy.com

Dr Harvey E. Bale, Jr
Director-General
International Federation of
Pharmaceutical
Manufacturers Associations
PO Box 758
1211 Geneva 13
022 338 32 00
022 338 32 99
admin@ifpma.org

Dr Jérôme Michel Barré
Head of the Pharmacology and
Toxicology Unit
Centre Hospitalier Intercommunal
Service de Pharmacologie
40, avenue de Verdun
94010 Créteil Cedex
+33 1 45 17 53 80
+33 1 45 17 53 72
+33 1 45 17 53 89
Jerome.Barre@chicreteil.fr

Dr Jaydip Bhaduri
Lupin Limited
Medical Director
159, CST Road
Kalina, Santacruz (E)
Mumbai 400 098, India
+91 22 56931001-10, Ext. 331
+91 22 26526842 (direct)
+91 22 26526755
+91 22 26540484
jaydipbhaduri@lupinpharma.com

Dr Nubia Boechat
Ministry of Health
Oswaldo Cruz Foundation
Institute of Drug Technology
Far-Manguinhos
Rua Sizenando Nabuco, 100
21041-250 Manguinhos
Rio de Janeiro
Brazil
+55 21 3977-2454/2455
+55 21 2290-1297
boechat@far.fiocruz.br

Mr Anthony F. Boni
USAID/GH/HIDN/HSD
Pharmaceutical Management Advisor
Office of Health, Infectious Diseases and
Nutrition
Room 3.07-073, 3rd floor, RRB
Washington, DC 20523-3700
USA
+1 202 712 4789
+1 202 216 3702
aboni@usaid.gov

Dr Robert Bwire
Berkenboog 24
5386 GC Geffen
The Netherlands
+31 735320418
+31 735320418
rbwire@planet.nl

Ms Cynthia Cannady
Director
World Intellectual Property
Organization
Intellectual Property Policy and New
Technologies
34, chemin des Colombettes
Geneva
cynthia.cannady@wipo.int

Mr Andrew Clark
Director of Medical Affairs
Infectious Diseases and Immunology,
Bristol Myers Squibb Company

Dr Jennie Connor
Senior Lecturer, Epidemiology
Section of Epidemiology and
Biostatistics
School of Population Health
University of Auckland
Private Bag 92019
Auckland
New Zealand
+64 9 3737599 Ext. 84400
+64 9 3737494
j.connor@auckland.ac.nz

Mr Robert Dintruff
Abbott International
Abbott Laboratories
Dept 06MQ
Building AP34-3
Abbott Park, IL 60064-6189
USA
+1 847 938 7945
+1 847 938 8497
rob.dintruff@abbott.com

Mr Jean-Pascal Ducret
Director
Sanofi-Synthelabo
Impact Malaria
82, avenue Raspail
94255 Gentilly Cedex
France
+33 1 41 24 65 11
+33 6 86 16 11 82
+33 1 41 24 61 24
Jean-Pascal.Ducret@sanofi-synthelabo.com

George Dunstan
Merck & Co., Inc.
One Merck Drive
PO Box 100
Whitehouse Station, NJ 08889-0100
USA

Dr Christopher J. Elias
President
Path (Programme for Appropriate
Technology in Health)
1455 NW Leary Way
Seattle, WA 98107
USA
+1 206 285 3500
+1 205 285 6619
celias@path.org

Dr Bernard Fourie
National TB Research Programme of the
Medical Research Council (MRC)
Programme Director
1 Soutpansberg Road
Private Bag X 385
0001 Pretoria
South Africa
+27 12 325 5970
bernard.fourie@mrc.ac.za

Ms Isabelle Girault
Director, HIV/AIDS
External Relations
Global Government Affairs & Public
Policy
GlaxoSmithKline
GSK Home CN10
980 Great West Road
Brentford
Middlesex TW8 9GS
United Kingdom
+44 20 8047 5488
+44 20 8047 6957
isabelle.s.girault@gsk.com

Mr Michiel de Goeje
IDA Foundation
Pharmaceutical Advisor & GMP
Compliance
QA Department
PO Box 37098
1030 AB Amsterdam
The Netherlands
+31 20 4033051
+31 20 4031854
mdgoeje@ida.nl

Dr Jaideep A Gogtay
Cipla Ltd
Mumbai Central
Mumbai 400 008
India
+91 309 5521
+91 308 2891
+91 414 9778 (res.)
+91 412 4359 (res.)
+91 22 23070013
+91 22 307 0393
+91 22 307 0385
jgogtay@cipla.com

Mr William F. Haddad
Chairman/CEO
Biogenerics, Inc.
Representing Cipla, Ltd (India)
120 Manor Road
Patterson, NY 12563
USA
+1 845 278 8800
+1 845 878 3046
+1 347 693 3322
+1 845 878 8015
wfhaddad@aol.com
biogenerics@aol.com

Mr Ton Hoek
General Secretary
Fédération internationale
pharmaceutique
Andries Bickerweg 5
2517 JP The Hague
PO Box 84200
2508 AE The Hague
The Netherlands
+31 70 3021870
+31 70 3021972 (direct)
+31 620139954
+31 70 3021999
hoek@fip.org

Dr David Hoos
Assistant Professor of Clinical
Epidemiology
Mailman School of Public Health
Columbia University
722 West 168th Street - Room 707
New York, NY 10032
USA
+1 212 342 0464
+1 212 342 0412
dh39@columbia.edu

Mr Sandeep Juneja HIV Project Head
Ranbaxy Laboratories Limited
Devika Tower
6, Nehru Place
New Delhi - 110019
India
+91 11 26002120 (direct)
+91 11 26452666-72 Extn. 2621
+91 11 26002121
SANDEEP.JUNEJA@ranbaxy.com

Dr Valérie Lameyre
Medical Manager
Impact Malaria
Sanofi-Synthelabo
82, avenue Raspail
94255 Gentilly Cedex
France
+33 1 41 24 63 64
+33 6 74 44 78 08
+33 1 41 24 61 24
valerie.lameyre@sanofi-synthelabo.com

Dr Joep M.A. Lange
Professor of Medicine
Chief Scientific Adviser
International Antiviral Therapy
Evaluation Center (IATEC BV).
Meibergdreef 99
1105 AZ Amsterdam
PO Box 22700
1100 DE Amsterdam
The Netherlands
+31 20 566 75 37 (direct)
+31 20 566 44 79
+31 20 691 88 21
j.lange@amc.uva.nl
jtongeren@amc.uva.nl

Dr David Lee
Deputy Director
Technical Strategy and Quality
Center for Pharmaceutical Management
Management Sciences for Health, Inc.
4301 North Fairfax Drive, Suite 400
Arlington, VA 22203-1627
USA
+1 703 524 6575
+1 703 248 1612 (direct)
+1 703 524 7898
dlee@msh.org

Ms Cécile Macé
Pharmacist
Médecins sans Frontières
Access to Essential Medicines
8, rue Saint-Sabin
75544 Paris Cedex 11
France
+33 1 4021 2758
+33 6 1404 5697
+33 1 48066868
cmace@paris.msf.org
cecilemace@hotmail.com

Mr Kevin Mak
Holleykin
Chongqing Holley Holding Co. Ltd
12/F, Guangyu Building
76 Jianxin North Road
Jiangbei District
Chongqing
China 400020
+86 23 67755788
kmak@china.com

Dr Lynn Marks
GlaxoSmithKline
Philadelphia, PA
USA
+1 610 917 5011
Lynn.G.Marks@gsk.com

Ms Jane E.N. Masiga
Head of Operations
Mission for Essential Drugs & Supplies (MEDS)
PO Box 78040
Viwandani
00507 Nairobi
Kenya
+254 20 551633
+254 20 551642
+254 20 551653
+254 734 600310
+254 722 202106
+254 20 556632
+254 20 556635
jmasiga@meds.or.ke
sahibu@africaonline.co.ke

Dr John B. Morris
Associate Director, CMC Project
Global Pharmaceutical Research and
Development
Abbott Laboratories
Dpt. R4R1, Bldg. R13-4
1401 Sheridan Road
North Chicago, IL 60064-6290
USA
+1 847 938 4996
+1 847 935 8000
john.b.morris@abbott.com

Dr Eric Noehrenberg
Director
International Trade and Market Issues
International Federation of
Pharmaceutical Manufacturers
Associations (IFPMA)
30, rue de St-Jean
PO Box 758
1211 Geneva 13
Switzerland
+41 22 338 32 00
+41 22 338 32 99
e.noehrenberg@ifpma@org

Dr Ramesh Panchagnula
National Institute of Pharmaceutical
Education and Research (NIPER)
Head of the Department of
Pharmaceutics
Sector 67
S.A.S. Nagar - 160 062
Punjab
India
+91 172 2214 682/685
+91 9815901875
+91 172 2214692
panchagnula@yahoo.com

Dr Atul K Patel
Chief: Department of Infectious Diseases
Sterling Hospital & ID Clinic
Adit Medical Centre
Navrangpura
Ahmedabad-380 009
Gujarat
India
+91 79 644 0816 (clinic)
+91 79 685 0708 (residence)
+91 79 644 0816
atulpatel@icenet.net

Ms Mariclaire T Payawal
Senior Director
Global Access Program
Bristol-Myers Squibb Company
Corporate Policy
PO Box 4000
Princeton, NJ 08543
USA
+1 609 252 4469
+1 609 456 8337
+1 609 252 7356
mariclaire.payawal@bms.com

Mr Bernard Pécoul
Médecins sans frontières
78, rue de Lausanne
PO Box 116
1211 Geneva 21
Switzerland
+41 22 849 84 84
022 849 8488
bernard.pecoul@geneva.msf.org

Mrs Hanne Bak Pedersen
UNICEF
UNICEF Plads
2100 Copenhagen OE
Denmark
+45 35 27 30 60
+45 35 26 94 21
hpedersen@unicef.org

Mr Greg Perry
International Generic Producers
Alliance (IGPA)
PO Box 193
B-1040 Brussels 4
Belgium
+32 2 736 8411
+32 2 736 7438
gperry@egagenerics.com

Mr Laurence Phillips
Head of Customer Group HIV-
Specialist/Virologist
Boehringer Ingelheim GmbH
55216 Ingelheim am Rhein
Germany
+49 6132 77 2081
+49 6132 77 3829
laurence.phillips@ing.boehringer-ingelheim.com

Dr János Pogány
Consivers Consulting & Translation
Group
Sasadi út 140
H-1112 Budapest
Hungary
+361 246 3341
+361 246 3341
pogany@axelero.hu

Dr Sanjay Pujari
Director HIV Unit
Ruby Hall Clinic
2, Jai Bhagirathi Apts.
881/B, Sadashiv Peth
Pune 411030
India
+91 9822058985
san1@medscape.com

Mr Rudy van Puymbroeck
The World Bank
Procurement Policy and Service Group,
OPCS VP
Global HIV-AIDS Program, HDN
1818 H Street N.W.
Room G8-135 MSN G8-802
Washington
USA

Dr Françoise Renaud-Théry
Care & Support Network Adviser,
SIF/SMI, UNAIDS
20, avenue Appia
1211 Geneva 27
Switzerland
022 791 36 66
022 791.41 87
theryf@unaids.org

Dr Renee Ridzon
Senior Program Officer
Bill & Melinda Gates Foundation
HIV, TB & Reproductive Health
1551 Eastlake Avenue
Seattle, Washington 98102
USA
+1 202 709 3383
+1 202 709 3170
reneer@gatesfoundation.org

Dr Lise Riopel
Scientific Officer
Medicines for Malaria Venture
International Center Cointrin
Block G, 3rd Floor
Route de Pré-Bois 20
PO Box 1826
1215 Geneva 15
Switzerland
+41 22 799 4070
+41 22 799 4061
riopell@mmv.org

Dr Reeta Roy
Divisional Vice President
Global Citizenship and Policy
Abbott Laboratories
Dept. 0383
Bldg. AP6D
100 Abbott Park Road
Abbott Park
IL 60064-6048
USA
+1 847 936 0645
+1 847 937 9555
reeta.roy@abbott.com

Dr Leonard Sacks
Medical Officer
U.S. Food and Drug Administration
Division of Special Pathogens and
Immunologic Drug Products
5600 Fishers Lane, HFD 590
Rockville MD 20857
USA
+1 301 827-2336
+1 301 827 2475
Sacksl@CDER.FDA.GOV

Dr Himadri Sen
President
Pharma Research & Regulatory Affairs
Lupin Limited
46A/47A, Nande Village
Mulshi Taluka
Pune 411 042
India
+91 20 512 6690
+91 20 512 6451
+91 20 512 6161/9
+91 98230 20111
+91 98230 38402
himadrisen@lupinpharma.com

Mr Dilip Shah
Secretary General
The Indian Pharmaceutical Alliance
Vision Consulting Group
201 Darvesh Chambers
2473 P.D. Hinduja Road
Khar, Mumbai 400 052
India
+91 2226 00 0632
+91 2226 00 0633
dgshah@vision-india.com

Mr Chang-Sik Shin
Director
R&D Department
Shin Poong Pharm. Co. Ltd
772, Yoksam-Dong, Kangnam-Ku
Seoul
Korea
+82 2 553 0241-5
+82 2 557 4372
shinpj@uriel.net

Dr Anthony So
Associate Director, Health Equity
The Rockfeller Foundation
420 Fifth Avenue
New York, NY 10018-2702
USA
+1 212 852 8340
+1 212 852 8279
aso@rockfound.org

Mr Robert Staley
Principal Program Associate
Management Sciences for Health
Center for Pharmaceutical Management
Mangement Sciences for Health, Inc.
4301 North Fairfax Drive, Suite 400
Arlington, Virginia 22203
USA
+1 703 524 6575
+1 703 248 1602 (direct)
+1 703 524 7898
rstaley@msh.org

Mr David Stanton
Global AIDS Coordinator Planning Task
Force (S/GAC)
Room 1004, Harry S Truman Building
U.S. Department of State
Washington, D.C. 20520
USA
+ 1 202 647 1145
+1 202 647 5792
StantonDL@state.gov

Mr Joe Steele
Vice President
Commercial Development
Gilead Sciences, Inc.
333 Lakeside Drive
Foster City, CA 94404
USA
+1 650 522 5740
+1 650 504 5375
+1 650 522 5696
jsteele@gilead.com

Mr Jeffrey Sturchio
Vice President, External Affairs
Europe, Middle East & Africa
Human Health
Merck & Co., Inc.
One Merck Drive
PO Box 100
Whitehouse Station, NJ 08889-0100
USA
+1 908 423 3981
+1 908 735 1704
jeffrey_sturchio@merck.com

Ms Yolanda Tayler
The World Bank
Procurement Policy and Service Group,
OPCS VP
Global HIV-AIDS Program, HDN
1818 H Street N.W.
Room G8-135 MSN G8-802
Washington
USA
+1 202 473 0810
+1 202 522 3317/3235
Ytayler@worldbank.org

Ms Ellen F.M. t'Hoen
Médecins sans frontières
Access to Essential Medicines Campaign
8, rue Saint-Sabin
75544 Paris cedex 11
France
+33 1 4021 2836
+33 6 22375871
+33 1 40212962
ellen.t.hoen@paris.msf.org

Mrs Trix Janet Tuin
Pharmacist, Medical Export Group BV
Manager Quality Assurance
Papland 16
PO Box 598
4200 AN Gorinchem
The Netherlands
+31 183 356 130
+31 183 356 131
tuin@meg.nl

Ms Maria Vigneau
Director, External Relations HIV/AIDS
F. Hoffmann-La Roche Ltd
Pharmaceuticals Division
Pharma International
Bldg 071/316
4070 Basel
Switzerland
+41 61 688 92 91
+41 79 506 99 41
+41 61 688 27 78
maria.vigneau@roche.com

Dr Susan Walters
Consultant
10 Maria Place
Lyons - ACT 2606
Australia
+61 2 6281 6948
+61 2 6281 6948
susan.walters@netspeed.com.au

Mr Witold Wieniawski
Polish Pharmaceutical Society
Dluga Street 16
00-283 Warsaw
Poland
+48 22 842 09 31
wwieniaw@prc.neostrada.pl

Mr Richard Wilder
Consultant IPR
Sidley, Austin, Brown & Wood
1501 K Street, N.W.
Washington, D.C. 20005
USA
+1 202 736 8017
+1 202 736 8711
rwilder@sidley.com

Dr Roger L. Williams
Executive Vice President and
Chief Executive Officer
The United States Pharmacopeia
12601 Twinbrook Parkway
Rockville, MD 20852-1790
USA
+1 301 816 8300
+1 301 816 8299
rlw@usp.org

WHO secretariat

Dr Jim Yong Kim
Adviser to the Director-General
x13910
kimj@who.int

Dr Vladimir K. Lepakhin
Assistant Director-General
Health Technology and Pharmaceuticals
(HTP)
x14417
lepakhinv@who.int

Dr Jack Chow
Assistant Director-General
HIV/AIDS TB and Malaria
x13800
chowj@who.int

Dr Jonathan D. Quick
Director
Essential Drugs and Medicines Policy
(EDM)
x 14443/13834
quickj@who.int

Dr H.V. Hogerzeil
Coordinator
Policy, Access and Rational Use,
EDM/PAR
x13528/14318
hogerzeilh@who.int

Dr Lembit Rägo
Coordinator
Quality Assurance & Safety, EDM/QSM
x14420/12657
ragol@who.int

Mr Peter Graaff
Policy, Access and Rational Use,
EDM/PAR
x14228
graaffp@who.int

Mr Rajesh Gupta
Director General Office
x13224
guptar@who.int

Dr Warren Kaplan (Rapporteur)
Policy, Access and Rational Use,
EDM/PAR
x12436
kaplanw@who.int

Dr Richard Laing (Secretary)
Policy, Access and Rational Use,
EDM/PAR
x14533
laingr@who.int

Ms Cecilia Oh
Drug Action Programme, EDM/DAP
x11547
ohc@who.int

Dr Clive Ondari
Policy, Access and Rational Use,
EDM/PAR
x13676/12902
ondaric@who.int

Mr Adriaan van Zyl
Quality Assurance & Safety, EDM/QSM
x13598/13527
vanzyla@who.int

Dr Sabine Kopp
Quality Assurance & Safety, EDM/QSM
13636/13642
kopps@who.int

Dr Pascale Vanbel
Quality Assurance & Safety, EDM/QSM
x13669/13642
vanbelp@who.int

Mr Olivier Gross
Quality Assurance & Safety, EDM/QSM
x14805
grosso@who.int

Ms Ivana Tasevska
Quality Assurance & Safety, EDM/QSM
x13717
tasevskai@who.int

Other WHO sections

Dr Virginia Arnold
Stop TB
x12399
arnoldv@who.int

Dr Mohammed Akhtar
Stop TB
x11895 akhtar@who.int
Dr Yevgeny Goryakin
Stop TB
x11278
goryakiny@who.int

Dr Ernesto Jaramillo
Stop TB
x13034/14650
jaramilloe@who.int

Dr Fabienne Jouberton
Stop TB
x11881
jouberton@who.int

Dr Thomas Kanyok (Rapporteur)
UNDP/World Bank/WHO Special
Programme for Research and Training
in Tropical Diseases
x13684
kanyokt@who.int

Dr Kayondo J.F. Kengeya
UNDP/World Bank/WHO Special
Programme for Research and Training
in Tropical Diseases
x13737
kengeyakayondo@who.int

Dr Robert H. Matiru
Stop TB
x13971
matirur@who.int

Dr Stéphanie Meredith
IMD/BLT
x12070
Dr Peter Olumese
Roll Back Malaria
x14424
olumesep@who.int

Dr Philip C. Onyebujoh
UNDP/World Bank/WHO Special
Programme for Research and Training
in Tropical Diseases
x14478
onyebujohp@who.in

Dr Joseph Perriens
Director, HIV/CRE
x14456/13477
perriensj@who.int

Dr Robert G. Ridley
Coordinator
Product Research and Development
x13767/13778
ridleyr@who.int

Dr Allan Schapira
Roll Back Malaria
x11864/13419
schapiraa@who.int

Dr Kenji Tamura
HIV/CRE
x11641
tamurak@who.int

Dr Walter R.J. Taylor
Product Research and Development,
TDR/PRD
x13853
taylorw@who.int

Dr Paulo Teixeira
Director, HIV/AIDS
x14642
teixeirap@who.int

Dr Marco Vitoria
HIV/CRE
x11949
vitoriam@who.int

Dr Hugo Vrakking
Stop TB
x14267
vrakkingh@who.int

Ir a la sección anterior
 

Última actualización: le 24 abril 2012